Projects per year
Epicardial adipose tissue (EAT) is a risk factor implicated in the pathogenesis and prognosis of cardiovascular disease. Metformin has been shown to regress EAT in animal models and observational studies. In this study, we report that metformin has no effect on EAT in patients with coronary artery disease without diabetes.
|Number of pages||2|
|Early online date||13 May 2021|
|Publication status||Published - Jun 2021|
- Cardiac MRI
- Coronary artery disease
- Epicardial adipose tissue
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Public Health, Environmental and Occupational Health
FingerprintDive into the research topics of 'Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: A cardiac MRI substudy of the MET-remodel trial'. Together they form a unique fingerprint.
- 2 Finished